Interactions between inflammation, sex steroids, and Alzheimer’s disease risk factors
Open accessThe DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
Abstract
Alzheimer’s disease (AD) is an age-related neurodegenerative disorder for which there are no effective strategies to prevent or slow its progression. Because AD is multifactorial, recent research has focused on understanding interactions among the numerous risk factors and mechanisms underlying the disease. One mechanism through which several risk factors may be acting is inflammation. AD is characterized by chronic inflammation that is observed before clinical onset of dementia. Several genetic and environmental risk factors for AD increase inflammation, including apolipoprotein E4, obesity, and air pollution. Additionally, sex steroid hormones appear to contribute to AD risk, with age-related losses of estrogens in women and androgens in men associated with increased risk. Importantly, sex steroid hormones have anti-inflammatory actions and can interact with several other AD risk factors. This review examines the individual and interactive roles of inflammation and sex steroid hormones in AD, as well as their relationships with the AD risk factors apolipoprotein E4, obesity, and air pollution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of Childhood and Adult Obesity in the United States, 2011-2012
Ogden, C. L., Carroll, M. D., Kit, B. K., & Flegal, K. M. (2014) · JAMA · doi:10.1001/jama.2014.732 · Cited by 8,072
Forouzanfar, M. H., Afshin, A., Alexander, L. T., Anderson, H. R., Bhutta, Z. A., Biryukov, S., Brauer, M., Burnett, R., Cercy, K., Charlson, F. J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31679-8 · Cited by 7,698
Brook, R. D., Rajagopalan, S., Pope, C. A., Brook, J. R., Bhatnagar, A., Diez-Roux, A. V., Holguin, F., Hong, Y., Luepker, R. V., Mittleman, M. A., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181dbece1 · Cited by 6,548 · cited 1×
“Therefore, air pollution exposure represents a risk for other major inflammatory diseases like pulmonary disease, cardiovascular disease, and stroke (Brook et al., 2010; Chauhan and Johnston, 2003; Liu et al., 2016).”
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819 · cited 2×
“Microbiome imbalance leads to increased intestinal permeability, translocation of bacteria to the bloodstream, and systemic inflammation (Cani et al., 2008).”
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336 · cited 2×
“CR1 in immune cells interacts with activated complement components and triggers the clearance of bound factors (Fonseca et al., 2016).”
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244 · cited 1×
“…the brain parenchyma for abnormalities (Sierra et al., 2015), under normal conditions microglia participate in many functions that promote neural health including synaptic pruning and remodeling (Paolicelli et al., 2011; Schafer et al., 2012) and synaptic plasticity (Parkhurst et al., 2013).”
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028 · cited 2×
“(Mahley, 1988).”
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690 · cited 1×
“TLR4 is of special interest because of the ability of saturated fatty acids to activate this receptor (Lee et al., 2001; Shi et al., 2006), although this effect is still controversial (Erridge and Samani, 2009).”
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343 · cited 1×
“Components of the complement signaling pathway can bind to fibrillar A(Afagh et al., 1996) as well as to neuronal synapses (Hong et al., 2016).”
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280 · cited 1×
“In turn, systemic inflammation and consumption of high-energy diet can disrupt the blood brain barrier and cause cognitive impairments (Kanoski et al., 2010; Zlokovic, 2008).”
Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis
Yona, S., Kim, K.-W., Wolf, Y., Mildner, A., Varol, D., Breker, M., Strauss-Ayali, D., Viukov, S., Guilliams, M., Misharin, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.12.001 · Cited by 3,245 · cited 2×
“…they differ to some extent from the macrophages that reside in other tissues: microglia originate from hematopoietic stem cells of the yolk cell during development and not from the bone-marrow, and they are long-lived cells that are able to self-renew (Ginhoux et al., 2010; Yona et al., 2013).”
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020 · cited 5×
“These immune-related genes include complement receptor 1 (CR1) (Lambert et al., 2013; Naj et al., 2011), triggering receptor expressed on myeloid cells 2 protein (TREM2) (Guerreiro et al., 2013), and CD33 (Hollingworth et al., 2011; Naj et al., 2011).”
InfluentialSubcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“Central or visceral adipose tissue appears to be especially problematic because it preferentially accumulates triglycerides and is less sensitive to insulin than other fat depots (Märin et al., 1992; Wajchenberg, 2000).”
Turnbaugh, P. J., Bäckhed, F., Fulton, L., & Gordon, J. I. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.02.015 · Cited by 2,915
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898 · cited 1×
“Deficiency of the NLRP3 inflammasome skews activated microglia towards an M2-like state in AD transgenic mice, resulting in increased Aβ clearance and enhanced tissue remodeling (Heneka et al., 2013).”
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760 · cited 2×
“androgen receptor (AR)-regulated tissues, altering metabolic processes and inflammatory responses (Harman et al., 2001; Maggio et al., 2005).”
Forouzanfar, M. H., Alexander, L., Anderson, H. R., Bachman, V. F., Biryukov, S., Brauer, M., Burnett, R., Casey, D., Coates, M. M., Cohen, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00128-2 · Cited by 2,701
Alzheimer disease in the United States (2010–2050) estimated using the 2010 census
Hebert, L. E., Weuve, J., Scherr, P. A., & Evans, D. A. (2013) · Neurology · doi:10.1212/wnl.0b013e31828726f5 · Cited by 2,642
Translocation of inhaled ultrafine particles to the brain
Oberdörster, G., Sharp, Z., Atudorei, V., Elder, A., Gelein, R., Kreyling, W., & Cox, C. (2004) · Inhalation Toxicology · doi:10.1080/08958370490439597 · Cited by 2,606
Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor
Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R., Lafaille, J. J., Hempstead, B. L., Littman, D. R., & Gan, W.-B. (2013) · Cell · doi:10.1016/j.cell.2013.11.030 · Cited by 2,599
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245 · cited 2×
“NFB activation alone can cause insulin resistance without steatosis, which suggests that inflammation interferes with insulin signaling (Cai et al., 2005).”
Shumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones III, B. N., Assaf, A. R., Jackson, R. D., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2651 · Cited by 2,178
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078 · cited 2×
“phagocytosis and increased cytokine production are associated with cognitive decline in AD (Mawuenyega et al., 2010; Orre et al., 2014).”
Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity
Markle, J. G. M., Frank, D. N., Mortin-Toth, S., Robertson, C. E., Feazel, L. M., Rolle-Kampczyk, U., von Bergen, M., McCoy, K. D., Macpherson, A. J., & Danska, J. S. (2013) · Science · doi:10.1126/science.1233521 · Cited by 2,025
Initiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997
Naj, A. C., Jun, G., Beecham, G. W., Wang, L.-S., Vardarajan, B. N., Buros, J., Gallins, P. J., Buxbaum, J. D., Jarvik, G. P., Crane, P. K., et al. (2011) · Nature Genetics · doi:10.1038/ng.801 · Cited by 1,901 · cited 1×
“These immune-related genes include complement receptor 1 (CR1) (Lambert et al., 2013; Naj et al., 2011), triggering receptor expressed on myeloid cells 2 protein (TREM2) (Guerreiro et al., 2013), and CD33 (Hollingworth et al., 2011; Naj et al., 2011).”
Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R. D., Shanahan, F., Dinan, T. G., & Cryan, J. F. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.77 · Cited by 1,893 · cited 2×
“Other studies have also demonstrated sex differences in microbiome manipulations, including altered BNDF and serotonin levels in germ-free male animals but not in females, which suggests that the sexes differ in their sensitivity to microbiome changes (Clarke et al., 2012).”
Obesity-induced inflammatory changes in adipose tissue
Wellen, K. E., & Hotamisligil, G. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320514 · Cited by 1,823
Role of Genes and Environments for Explaining Alzheimer Disease
Gatz, M., Reynolds, C. A., Fratiglioni, L., Johansson, B., Mortimer, J. A., Berg, S., Fiske, A., & Pedersen, N. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.168 · Cited by 1,798 · cited 1×
“Modifiers of Alzheimer’s disease risk and their interaction with inflammation and sex steroid hormones The degree of heritability and development of AD varies greatly in the human population (Coon et al., 2007; Gatz et al., 2006).”
Neuroinflammation and M2 Microglia: The Good, the Bad, and the Inflamed
Cherry, J. D., Olschowka, J. A., & O’Banion, M. K. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-98 · Cited by 1,748 · cited 1×
“AD is characterized by several neuropathological features, including the accumulation of amyloid β (Aβ) and hyperphosphorylated tau, gliosis, and synaptic and neuron loss (Cherry et al., 2014; Glass et al., 2010; LaFerla, 2010; Morris et al., 2014).”
The role of apolipoprotein E in Alzheimer's disease
Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661 · cited 1×
“…and apoE4 have important effects on biological functions including synaptogenesis, mitochondrial function, brain volume, and A clearance (Cedazo-Mínguez, 2007; Huang, 2010; Kim et al., 2009), as well as on risk of cardiovascular disease and atherosclerosis (Hixson, 1991; Stengard et al., 1998).”
Stewart, C. R., Stuart, L. M., Wilkinson, K., van Gils, J. M., Deng, J., Halle, A., Rayner, K. J., Boyer, L., Zhong, R., Frazier, W. A., et al. (2010) · Nature Immunology · doi:10.1038/ni.1836 · Cited by 1,513 · cited 1×
“TLR4 can bind to A, leading to activation of the transcription factor NFB and increased expression of inflammation-related genes (Landreth and Reed-Geaghan, 2009; Stewart et al., 2009).”
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O. (2003) · Nature Medicine · doi:10.1038/nm840 · Cited by 1,397 · cited 2×
“immunotherapy enhances plaque clearance, and reduces microglia and astrocyte activation (Nicoll et al., 2003; Zotova et al., 2013).”
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease
Prinz, M., & Priller, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3722 · Cited by 1,329 · cited 3×
“One important role for microglia in AD is their participation in A clearance (Prinz and Priller, 2014).”
InfluentialLee, J. Y., Sohn, K. H., Rhee, S. H., & Hwang, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011695200 · Cited by 1,299 · cited 3×
“Importantly, TLR4 interacts with other modulators of AD, including apoE4 (Tai et al., 2015), saturated fatty acids (Lee et al., 2001), and pollution particulate matter (Bauer et al., 2012).”
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
Bell, R. D., Winkler, E. A., Singh, I., Sagare, A. P., Deane, R., Wu, Z., Holtzman, D. M., Betsholtz, C., Armulik, A., Sallstrom, J., et al. (2012) · Nature · doi:10.1038/nature11087 · Cited by 1,293 · cited 2×
“Interestingly, apoE4 has less affinity for LPR1 than do apoE2 and apoE3 (Bell et al., 2012).”
Increased adipose tissue in male and female estrogen receptor-α knockout mice
Heine, P. A., Taylor, J. A., Iwamoto, G. A., Lubahn, D. B., & Cooke, P. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12729 · Cited by 1,282
Human ApoE isoforms differentially regulate brain amyloid-β peptide clearance
Castellano, J. M., Kim, J., Stewart, F. R., Jiang, H., DeMattos, R. B., Patterson, B. W., Fagan, A. M., Morris, J. C., Mawuenyega, K. G., Cruchaga, C., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002156 · Cited by 1,242 · cited 1×
“Moreover, the lipidation state of apoE determines its half-life in brain, its ability to inhibit neuroinflammation, and its ability to bind and clear A through receptors in the blood-brain barrier (Castellano et al., 2011; Hirsch-Reinshagen et al., 2004; Holtzman et al., 2000; Tai et al., 2015).”
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B., & Brooks, D. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.002 · Cited by 1,200 · cited 2×
“, 1997), Parkinson’s disease (Gerhard et al., 2006), Huntington’s”
Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
Bu, G. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2620 · Cited by 1,168
Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study
Whitmer, R. A., Gunderson, E. P., Barrett-Connor, E., Quesenberry, C. P., & Yaffe, K. (2005) · BMJ · doi:10.1136/bmj.38446.466238.e0 · Cited by 1,090
ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Cramer, P. E., Cirrito, J. R., Wesson, D. W., Lee, C. Y. D., Karlo, J. C., Zinn, A. E., Casali, B. T., Restivo, J. L., Goebel, W. D., James, M. J., et al. (2012) · Science · doi:10.1126/science.1217697 · Cited by 1,050 · cited 1×
“Thus, counteracting apoE4 effects by increasing apoE levels or lipidation status has been shown to ameliorate AD pathology in several mouse models of AD (Cramer et al., 2012; Jiang et al., 2008a; Wahrle et al., 2008).”
The metabolic syndrome, inflammation, and risk of cognitive decline
Yaffe, K. (2004) · JAMA · doi:10.1001/jama.292.18.2237 · Cited by 1,025 · cited 1×
“During this period, adiposity is correlated with obesity-related vascular diseases, increased inflammation, and changes in blood-brain barrier integrity and brain morphology (Emmerzaal et al., 2015; Gustafson et al., 2007; Pannacciulli et al., 2006; Yaffe et al., 2004).”
NF-kB: a crucial transcription factor for glial and neuronal cell function
O'Neill, L. A. J., & Kaltschmidt, C. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01035-1 · Cited by 1,013 · cited 1×
“NFB is a key transcription factor involved in inflammation, cell division, and apoptosis (ONeill and Kaltschmidt, 1997).”
Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
Griciuc, A., Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., Hooli, B., Choi, S. H., Hyman, B. T., & Tanzi, R. E. (2013) · Neuron · doi:10.1016/j.neuron.2013.04.014 · Cited by 1,004
Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature
Wyss-Coray, T., & Rogers, J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006346 · Cited by 975 · cited 1×
“Inflammation is a key pathological component in AD that has been proposed as a major mechanism both in the initiation and progression of the disease (Wyss-Coray and Rogers, 2012).”
Kumar, D. K. V., Choi, S. H., Washicosky, K. J., Eimer, W. A., Tucker, S., Ghofrani, J., Lefkowitz, A., McColl, G., Goldstein, L. E., Tanzi, R. E., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf1059 · Cited by 971 · cited 1×
“An interesting development in support of this hypothesis is the recent finding that A can act as a pore-forming antimicrobial peptide, suggesting that A accumulation could occur in response to infection (Kumar et al., 2016).”
Holtzman, D. M., Bales, K. R., Tenkova, T., Fagan, A. M., Parsadanian, M., Sartorius, L. J., Mackey, B., Olney, J., McKeel, D., Wozniak, D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050004797 · Cited by 937 · cited 1×
“Moreover, the lipidation state of apoE determines its half-life in brain, its ability to inhibit neuroinflammation, and its ability to bind and clear A through receptors in the blood-brain barrier (Castellano et al., 2011; Hirsch-Reinshagen et al., 2004; Holtzman et al., 2000; Tai et al., 2015).”
Calderón-Garcidueñas, L., Solt, A. C., Henríquez-Roldán, C., Torres-Jardón, R., Nuse, B., Herritt, L., Villarreal-Calderón, R., Osnaya, N., Stone, I., García, R., et al. (2008) · Toxicologic Pathology · doi:10.1177/0192623307313011 · Cited by 937
Adult mouse astrocytes degrade amyloid-β in vitro and in situ
Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., & Husemann, J. (2003) · Nature Medicine · doi:10.1038/nm838 · Cited by 909
Sex modifies the APOE ‐related risk of developing Alzheimer disease
Altmann, A., Tian, L., Henderson, V. W., Greicius, M. D., & Alzheimer's Disease Neuroimaging Initiative Investigators (2014) · Annals of Neurology · doi:10.1002/ana.24135 · Cited by 891 · cited 3×
“Importantly, APOE4 increases risk of AD significantly more strongly in women than it does in men (Altmann et al., 2014; Farrer et al., 1997; Payami et al., 1994), but how APOE4 and sex interact is still unclear.”
ApoE Promotes the Proteolytic Degradation of Aβ
Jiang, Q., Lee, C. Y. D., Mandrekar, S., Wilkinson, B., Cramer, P., Zelcer, N., Mann, K., Lamb, B., Willson, T. M., Collins, J. L., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.010 · Cited by 876 · cited 2×
“Cholesterol efflux activity is apoE isoform- dependent and APOE4 carriers have poorer efficiency of cholesterol efflux, which possibly contributes to the higher risk of AD in APOE4 carriers (Hara, 2002; Jiang et al., 2008a; 2008b; Michikawa et al., 2000).”
Rocca, W. A., Bower, J. H., Maraganore, D. M., Ahlskog, J. E., Grossardt, B. R., de Andrade, M., & Melton, L. J. (2007) · Neurology · doi:10.1212/01.wnl.0000276984.19542.e6 · Cited by 827
Ablation of CD11c-Positive Cells Normalizes Insulin Sensitivity in Obese Insulin Resistant Animals
Patsouris, D., Li, P.-P., Thapar, D., Chapman, J., Olefsky, J. M., & Neels, J. G. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.015 · Cited by 804 · cited 1×
“In support of this position, deletion of macrophages can restore insulin and glucose homeostasis associated with obesity (Patsouris et al., 2008).”
Central obesity and increased risk of dementia more than three decades later
Whitmer, R. A., Gustafson, D. R., Barrett-Connor, E., Haan, M. N., Gunderson, E. P., & Yaffe, K. (2008) · Neurology · doi:10.1212/01.wnl.0000306313.89165.ef · Cited by 803 · cited 1×
“In the case of AD, central adiposity may be the best metabolic predictor of disease risk (Luchsinger et al., 2012; Whitmer et al., 2008).”
Midlife and Late-Life Obesity and the Risk of Dementia: Cardiovascular Health Study
Fitzpatrick, A. L., Kuller, L. H., Lopez, O. L., Diehr, P., O’Meara, E. S., Longstreth, W. T., & Luchsinger, J. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.582 · Cited by 796
Malkin, C. J., Pugh, P. J., Jones, R. D., Kapoor, D., Channer, K. S., & Jones, T. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031069 · Cited by 731
The genetics of Alzheimer disease
Tanzi, R. E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006296 · Cited by 727
Fleminger, S. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.7.857 · Cited by 719
Spangenberg, E. E., Lee, R. J., Najafi, A. R., Rice, R. A., Elmore, M. R. P., Blurton-Jones, M., West, B. L., & Green, K. N. (2016) · Brain · doi:10.1093/brain/aww016 · Cited by 695
Sex differences in microglial colonization of the developing rat brain
Schwarz, J. M., Sholar, P. W., & Bilbo, S. D. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07630.x · Cited by 672
Sex Differences in the Clinical Manifestations of Alzheimer Disease Pathology
Barnes, L. L., Wilson, R. S., Bienias, J. L., Schneider, J. A., Evans, D. A., & Bennett, D. A. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.685 · Cited by 643
Holtman, I. R., Raj, D. D., Miller, J. A., Schaafsma, W., Yin, Z., Brouwer, N., Wes, P. D., Möller, T., Orre, M., Kamphuis, W., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0203-5 · Cited by 619 · cited 2×
“This classification system has been extended to microglia as well, but it cannot account for the entire range of phenotypes that can be found in the brain, especially under chronic inflammatory conditions (David and Kroner, 2011; Holtman et al., 2015).”
Relationship Between Education and Dementia: An Updated Systematic Review
Sharp, E. S., & Gatz, M. (2011) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318211c83c · Cited by 591 · cited 4×
“For example, the following factors have been shown to have a positive correlation with AD risk: lower education (Ferrari et al., 2014; Sharp and Gatz, 2011), head injury (Breunig et al.”
InfluentialApolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides
Koistinaho, M., Lin, S., Wu, X., Esterman, M., Koger, D., Hanson, J., Higgs, R., Liu, F., Malkani, S., Bales, K. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1058 · Cited by 571 · cited 2×
“(Kolstinaho et al., 2004) and astrocyte-dependent lipidation of apoE increases the ability of”
CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology
Initiative, T. A. D. N., Bradshaw, E. M., Chibnik, L. B., Keenan, B. T., Ottoboni, L., Raj, T., Tang, A., Rosenkrantz, L. L., Imboywa, S., Lee, M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3435 · Cited by 570 · cited 2×
“CD33 is found in monocytes and contains an immunoreceptor that is typically an inhibitor of cellular activity (Bradshaw et al., 2013).”
Coon, K. D., Myers, A. J., Craig, D. W., Webster, J. A., Pearson, J. V., Lince, D. H., Zismann, V. L., Beach, T. G., Leung, D., Bryden, L., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0419 · Cited by 569
HSP72 protects against obesity-induced insulin resistance
Chung, J., Nguyen, A.-K., Henstridge, D. C., Holmes, A. G., Chan, M. H. S., Mesa, J. L., Lancaster, G. I., Southgate, R. J., Bruce, C. R., Duffy, S. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705799105 · Cited by 553
Enzi, G., Gasparo, M., Biondetti, P., Fiore, D., Semisa, M., & Zurlo, F. (1986) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/44.6.739 · Cited by 547 · cited 2×
“distribution of fat differs between sexes, with abdominal visceral fat being more prevalent in men than in women (Bouchard et al., 1993; Enzi et al., 1986).”
Interleukin-6 and risk of cognitive decline: MacArthur Studies of Successful Aging
Weaver, J. D., Huang, M.-H., Albert, M., Harris, T., Rowe, J. W., & Seeman, T. E. (2002) · Neurology · doi:10.1212/wnl.59.3.371 · Cited by 536
Olmos-Alonso, A., Schetters, S. T. T., Sri, S., Askew, K., Mancuso, R., Vargas-Caballero, M., Holscher, C., Perry, V. H., & Gomez-Nicola, D. (2016) · Brain · doi:10.1093/brain/awv379 · Cited by 532
Sex differences in cognitive impairment and Alzheimer’s disease
Li, R., & Singh, M. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.01.002 · Cited by 527
Microglia Are Essential to Masculinization of Brain and Behavior
Lenz, K. M., Nugent, B. M., Haliyur, R., & McCarthy, M. M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1268-12.2013 · Cited by 526 · cited 2×
“The associations between sex, sexual differentiation, and microglia (Lenz et al., 2013; Schwarz et al., 2012) suggest interesting possible links with APOE4”
Brain abnormalities in human obesity: A voxel-based morphometric study
Pannacciulli, N., Del Parigi, A., Chen, K., Le, D. S. N. T., Reiman, E. M., & Tataranni, P. A. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.01.047 · Cited by 523
Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's Disease
Morris, G. P., Clark, I. A., & Vissel, B. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0135-5 · Cited by 522
Colangelo, V., Schurr, J., Ball, M. J., Pelaez, R. P., Bazan, N. G., & Lukiw, W. J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10351 · Cited by 517 · cited 2×
“are further increased in the context of AD (Blalock et al., 2005; Colangelo et al., 2002).”
Role of toll-like receptor signalling in A uptake and clearance
Tahara, K., Kim, H.-D., Jin, J.-J., Maxwell, J. A., Li, L., & Fukuchi, K.-I. (2006) · Brain · doi:10.1093/brain/awl249 · Cited by 493 · cited 1×
“Microglia can sense Avia cell-surface receptors including the toll-like family of receptors (TLR) (Fassbender et al., 2003; Salminen et al., 2009; Tahara et al., 2006).”
Genetic and Nongenetic Determinants of Regional Fat Distribution
BOUCHARD, C., DESPRÉS, J.-P., & MAURIÈGE, P. (1993) · Endocrine Reviews · doi:10.1210/er.14.1.72 · Cited by 486
Krabbe, G., Halle, A., Matyash, V., Rinnenthal, J. L., Eom, G. D., Bernhardt, U., Miller, K. R., Prokop, S., Kettenmann, H., & Heppner, F. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060921 · Cited by 478 · cited 1×
“However, in mice with AD-like pathology, microglial motility and A phagocytosis are impaired even though cytokine production is increased (Krabbe et al., 2013).”
Wahrle, S. E., Jiang, H., Parsadanian, M., Legleiter, J., Han, X., Fryer, J. D., Kowalewski, T., & Holtzman, D. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407963200 · Cited by 474
Kitazawa, M., Cheng, D., Tsukamoto, M. R., Koike, M. A., Wes, P. D., Vasilevko, V., Cribbs, D. H., & LaFerla, F. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100620 · Cited by 473 · cited 2×
“…IL-1 production promotes APP processing and tau pathology, contributing to impaired synaptic plasticity and memory formation (Pickering and O’Connor, 2007; Sheng et al., 2000), and neutralizing antibodies against IL-1 improve cognitive deficits in an AD mouse model (Kitazawa et al., 2011).”
Brosseron, F., Krauthausen, M., Kummer, M., & Heneka, M. T. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8657-1 · Cited by 447
The impact of systemic infection on the progression of neurodegenerative disease
Perry, V. H., Newman, T. A., & Cunningham, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1032 · Cited by 428 · cited 1×
“In general, infections are associated with increased risk of AD (Alonso et al., 2014; Miklossy, 2011; Nee and Lippa, 1999; Perry et al., 2003) and some viral infections may actively contribute to AD pathogenesis, since pathogens that evade elimination by the immune system lead to chronic…”
Blocking TGF-β–Smad2/3 innate immune signaling mitigates Alzheimer-like pathology
Town, T., Laouar, Y., Pittenger, C., Mori, T., Szekely, C. A., Tan, J., Duman, R. S., & Flavell, R. A. (2008) · Nature Medicine · doi:10.1038/nm1781 · Cited by 422 · cited 1×
“Blocking TGF in peripheral macrophages results in their infiltration into the brain and increases clearance of A plaques (Town et al., 2008).”
PAPADOPOULOS, V. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-2-222 · Cited by 417 · cited 2×
“TSPO expression is upregulated by glial cells under conditions of neuronal injury and inflammation (Papadopoulos, 1993; Vowinckel et al., 1997).”
Marsh, S. E., Abud, E. M., Lakatos, A., Karimzadeh, A., Yeung, S. T., Davtyan, H., Fote, G. M., Lau, L., Weinger, J. G., Lane, T. E., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525466113 · Cited by 411
Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease
Wahrle, S. E., Jiang, H., Parsadanian, M., Kim, J., Li, A., Knoten, A., Jain, S., Hirsch-Reinshagen, V., Wellington, C. L., Bales, K. R., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33622 · Cited by 407 · cited 1×
“Thus, counteracting apoE4 effects by increasing apoE levels or lipidation status has been shown to ameliorate AD pathology in several mouse models of AD (Cramer et al., 2012; Jiang et al., 2008a; Wahrle et al., 2008).”
Steroid hormone receptor expression and function in microglia
Sierra, A., Gottfried‐Blackmore, A., Milner, T. A., McEwen, B. S., & Bulloch, K. (2008) · Glia · doi:10.1002/glia.20644 · Cited by 405 · cited 2×
“…whether ER or ER is more important in mediating the effects of E2 on microglial responsiveness to insults (Baker et al., 2004; Saijo et al., 2011; Sierra et al., 2008; Vegeto et al., 2006; 2003; Wu et al., 2013), although the activation of both receptors by ER ligands appear to induce…”
Rone, M. B., Fan, J., & Papadopoulos, V. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.03.001 · Cited by 399
Hwang, L., Wang, C., Li, T., Chang, S., Lin, L., Chen, C., Chen, C., Liang, K., Ho, I., Yang, W., et al. (2010) · Obesity · doi:10.1038/oby.2009.273 · Cited by 395
Lynch, J. R., Tang, W., Wang, H., Vitek, M. P., Bennett, E. R., Sullivan, P. M., Warner, D. S., & Laskowitz, D. T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306923200 · Cited by 394
Isolation of glia from Alzheimer’s mice reveals inflammation and dysfunction
Orre, M., Kamphuis, W., Osborn, L. M., Jansen, A. H. P., Kooijman, L., Bossers, K., & Hol, E. M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.06.004 · Cited by 394
Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis
Papadopoulos, V., Amri, H., Boujrad, N., Cascio, C., Culty, M., Garnier, M., Hardwick, M., Li, H., Vidic, B., Brown, A. S., et al. (1997) · Steroids · doi:10.1016/s0039-128x(96)00154-7 · Cited by 386
Deficiency of ABCA1 Impairs Apolipoprotein E Metabolism in Brain
Hirsch-Reinshagen, V., Zhou, S., Burgess, B. L., Bernier, L., McIsaac, S. A., Chan, J. Y., Tansley, G. H., Cohn, J. S., Hayden, M. R., & Wellington, C. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407962200 · Cited by 385 · cited 1×
“Moreover, the lipidation state of apoE determines its half-life in brain, its ability to inhibit neuroinflammation, and its ability to bind and clear A through receptors in the blood-brain barrier (Castellano et al., 2011; Hirsch-Reinshagen et al., 2004; Holtzman et al., 2000; Tai et al., 2015).”
Matrix Metalloproteinases Expressed by Astrocytes Mediate Extracellular Amyloid-β Peptide Catabolism
Yin, K.-J., Cirrito, J. R., Yan, P., Hu, X., Xiao, Q., Pan, X., Bateman, R., Song, H., Hsu, F.-F., Turk, J., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2085-06.2006 · Cited by 381
Blasko, I., Stampfer‐Kountchev, M., Robatscher, P., Veerhuis, R., Eikelenboom, P., & Grubeck‐Loebenstein, B. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00101.x · Cited by 374
Levesque, S., Taetzsch, T., Lull, M. E., Kodavanti, U., Stadler, K., Wagner, A., Johnson, J. A., Duke, L., Kodavanti, P., Surace, M. J., et al. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002986 · Cited by 371
Il10 Deficiency Rebalances Innate Immunity to Mitigate Alzheimer-Like Pathology
Guillot-Sestier, M.-V., Doty, K. R., Gate, D., Rodriguez, J., Leung, B. P., Rezai-Zadeh, K., & Town, T. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.068 · Cited by 363
Predicting Time to Nursing Home Care and Death in Individuals With Alzheimer Disease
Stern, Y. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340040030 · Cited by 359 · cited 2×
“sexes, with men showing a more rapid progression (Lapane et al., 2001; Stern et al., 1997), but women showing greater severity for clinical dementia (Barnes et al.”
Interleukin-6, a mental cytokine
Spooren, A., Kolmus, K., Laureys, G., Clinckers, R., De Keyser, J., Haegeman, G., & Gerlo, S. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2011.01.002 · Cited by 352 · cited 2×
“contributes to APP processing and neurofibrillary tangle formation (Spooren et al., 2011), and its levels are correlated with cognitive decline in humans (Weaver et al.”
Neuroinflammatory TNFα Impairs Memory via Astrocyte Signaling
Habbas, S., Santello, M., Becker, D., Stubbe, H., Zappia, G., Liaudet, N., Klaus, F. R., Kollias, G., Fontana, A., Pryce, C. R., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.023 · Cited by 347 · cited 1×
“For instance, elevated levels of TNF can cause memory impairment in the hippocampus through TNFR1 activation in astrocytes (Habbas et al., 2015).”
Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
Riddell, D. R., Zhou, H., Atchison, K., Warwick, H. K., Atkinson, P. J., Jefferson, J., Xu, L., Aschmies, S., Kirksey, Y., Hu, Y., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1972-08.2008 · Cited by 346 · cited 1×
“A similar outcome is observed in mice, in which there is a faster turnover and lower steady state concentration of apoE, as well as greater inflammation, in APOE4-TR mice (Riddell et al., 2008).”
Absence of C1q Leads to Less Neuropathology in Transgenic Mouse Models of Alzheimer's Disease
Fonseca, M. I., Zhou, J., Botto, M., & Tenner, A. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0901-04.2004 · Cited by 345 · cited 2×
“could be either beneficial or detrimental in the context of AD (Fonseca et al., 2004).”
Kim, D.-G., Krenz, A., Toussaint, L. E., Maurer, K. J., Robinson, S.-A., Yan, A., Torres, L., & Bynoe, M. S. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0467-5 · Cited by 330
Chakrabarty, P., Jansen‐West, K., Beccard, A., Ceballos‐Diaz, C., Levites, Y., Verbeeck, C., Zubair, A. C., Dickson, D., Golde, T. E., & Das, P. (2010) · The FASEB Journal · doi:10.1096/fj.09-141754 · Cited by 328
Systemic markers of inflammation and cognitive decline in old age
Schram, M. T., Euser, S. M., De Craen, A. J. M., Witteman, J. C., Frölich, M., Hofman, A., Jolles, J., Breteler, M. M. B., & Westendorp, R. G. J. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01159.x · Cited by 326 · cited 1×
“Interestingly, non-steroidal anti-inflammatory drugs have been found to reduce risk for AD only in apoE4 carriers (Barger and Harmon, 1997; Schram et al., 2007), reinforcing the idea that there are important interactions between apoE4 and inflammation in”
Kanoski, S. E., Zhang, Y., Zheng, W., & Davidson, T. L. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091414 · Cited by 324
Ribas, V., Nguyen, M. T. A., Henstridge, D. C., Nguyen, A.-K., Beaven, S. W., Watt, M. J., & Hevener, A. L. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00504.2009 · Cited by 309 · cited 1×
“Likewise, male and female ER knockout mice have increased adiposity, as well as insulin resistance and impaired glucose tolerance (Heine et al., 2000; Ribas et al., 2010).”
The LPS receptor (CD14) links innate immunity with Alzheimer's disease
Fassbender, K., Walter, S., Kühl, S., Landmann, R., Ishii, K., Bertsch, T., Stalder, A. K., Muehlhauser, F., Liu, Y., Ulmer, A. J., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0364fje · Cited by 307 · cited 11×
“TLR4 is of special interest because of the ability of saturated fatty acids to activate this receptor (Lee et al., 2001; Shi et al., 2006), although this effect is still controversial (Erridge and Samani, 2009).”
InfluentialHepatocyte Toll-like receptor 4 regulates obesity-induced inflammation and insulin resistance
Jia, L., Vianna, C. R., Fukuda, M., Berglund, E. D., Liu, C., Tao, C., Sun, K., Liu, T., Harper, M. J., Lee, C. E., et al. (2014) · Nature Communications · doi:10.1038/ncomms4878 · Cited by 294 · cited 12×
“…mice maintained on HFD exhibited improved metabolic and inflammatory parameters, including ameliorated steatosis, glucose tolerance, insulin sensitivity, and reduced expression of pro-inflammatory cytokines in plasma, fat and liver, in comparison to wild-type mice fed HFD (Jia et al., 2014).”
InfluentialLowered testosterone in male obesity: Mechanisms, morbidity and management
Grossmann, M., Tang Fui, M., & Dupuis, P. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.122365 · Cited by 293
The dual roles of cytokines in Alzheimer’s disease: update on interleukins, TNF-α, TGF-β and IFN-γ
Zheng, C., Zhou, X.-W., & Wang, J.-Z. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-016-0054-4 · Cited by 292
Greater cognitive deterioration in women than men with Alzheimer's disease: A meta analysis
Irvine, K., Laws, K. R., Gale, T. M., & Kondel, T. K. (2012) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2012.712676 · Cited by 290
Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease
Rosario, E. R., Chang, L., Head, E. H., Stanczyk, F. Z., & Pike, C. J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.008 · Cited by 289 · cited 2×
“Low circulating levels of 17-estradiol (E2) are associated with AD (Rosario et al., 2011; Yue et al., 2005), and women with AD have lower brain levels of estrogens than age-matched cognitively normal controls (Rosario et al., 2011; Yue et al., 2005).”
Self-citationHigh-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model
Julien, C., Tremblay, C., Phivilay, A., Berthiaume, L., Émond, V., Julien, P., & Calon, F. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.08.022 · Cited by 288
Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model
Hirata-Fukae, C., Li, H.-F., Hoe, H.-S., Gray, A. J., Minami, S. S., Hamada, K., Niikura, T., Hua, F., Tsukagoshi-Nagai, H., Horikoshi-Sakuraba, Y., et al. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.079 · Cited by 284
Rocca, W. A., Grossardt, B. R., & Shuster, L. T. (2011) · Brain Research · doi:10.1016/j.brainres.2010.10.031 · Cited by 283 · cited 1×
“Physiological levels of E2 are generally protective, therefore the decrease in E2 levels during menopause and perimenopause offers an explanation to the pro-inflammatory profile seen in aged female brains (Rocca et al., 2011; M. X. Tang et al., 1996).”
Carroll, J. C., Rosario, E. R., Kreimer, S., Villamagna, A., Gentzschein, E., Stanczyk, F. Z., & Pike, C. J. (2010) · Brain Research · doi:10.1016/j.brainres.2010.10.009 · Cited by 273
Self-citationInflammatory components in human Alzheimer’s disease and after active amyloid-β42 immunization
Zotova, E., Bharambe, V., Cheaveau, M., Morgan, W., Holmes, C., Harris, S., Neal, J. W., Love, S., Nicoll, J. A. R., & Boche, D. (2013) · Brain · doi:10.1093/brain/awt210 · Cited by 272 · cited 2×
“immunotherapy enhances plaque clearance, and reduces microglia and astrocyte activation (Nicoll et al., 2003; Zotova et al., 2013).”
APOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease
Youmans, K. L., Tai, L. M., Nwabuisi-Heath, E., Jungbauer, L., Kanekiyo, T., Gan, M., Kim, J., Eimer, W. A., Estus, S., Rebeck, G. W., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.407957 · Cited by 268 · cited 1×
“In animal models, APOE4 is also linked to greater AD-like pathology, where it has been shown to potentiate oligomerization of Aβ (Belinson and Michaelson, 2009) and accelerate Aβ plaque formation (Youmans et al., 2012).”
CD33 Alzheimer’s risk-altering polymorphism, CD33 expression, and exon 2 splicing
Malik, M., Simpson, J. F., Parikh, I., Wilfred, B. R., Fardo, D. W., Nelson, P. T., & Estus, S. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1224-13.2013 · Cited by 262
Glial expression of estrogen and androgen receptors after rat brain injury
García‐Ovejero, D., Veiga, S., García‐Segura, L. M., & Doncarlos, L. L. (2002) · Journal of Comparative Neurology · doi:10.1002/cne.10325 · Cited by 261
Blasko, I., Veerhuis, R., Stampfer-Kountchev, M., Saurwein-Teissl, M., Eikelenboom, P., & Grubeck-Loebenstein, B. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0321 · Cited by 258 · cited 1×
“Human astrocytes synthesize Aβ- 40 and -42 when stimulated by IF, TNF or IL-1, events that can occur early in AD development (Blasko et al., 2000; Monson et al., 2014).”
CORDER, E. H., GHEBREMEDHIN, E., TAYLOR, M. G., THAL, D. R., OHM, T. G., & BRAAK, H. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1297.005 · Cited by 254 · cited 1×
“Moreover, the progression of the disease differs between sexes, with men showing a more rapid progression (Lapane et al., 2001; Stern et al., 1997), but women showing greater severity for clinical dementia (Barnes et al., 2005; Corder et al., 2004; Irvine et al., 2012).”
Hauet, T., Yao, Z.-X., Bose, H. S., Wall, C. T., Han, Z., Li, W., Hales, D. B., Miller, W. L., Culty, M., & Papadopoulos, V. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0307 · Cited by 252 · cited 1×
“For instance, when TSPO is knocked down, steroidogenesis is impaired (Kelly-Hershkovitz et al., 1998; Hauet et al., 2005) and levels of pro- inflammatory cytokines are increased (Bae et al., 2014).”
Michikawa, M., Fan, Q., Isobe, I., & Yanagisawa, K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741008.x · Cited by 244 · cited 1×
“Cholesterol efflux activity is apoE isoform- dependent and APOE4 carriers have poorer efficiency of cholesterol efflux, which possibly contributes to the higher risk of AD in APOE4 carriers (Hara, 2002; Jiang et al., 2008a; 2008b; Michikawa et al., 2000).”
Tu, L. N., Morohaku, K., Manna, P. R., Pelton, S. H., Butler, W. R., Stocco, D. M., & Selvaraj, V. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.578286 · Cited by 239 · cited 2×
“demonstrated that steroid levels and fertility were not affected by the absence of this protein (Morohaku et al., 2014; Tu et al., 2014).”
The role of aromatization in testosterone supplementation: Effects on cognition in older men
Cherrier, M. M., Matsumoto, A. M., Amory, J. K., Ahmed, S., Bremner, W., Peskind, E. R., Raskind, M. A., Johnson, M., & Craft, S. (2005) · Neurology · doi:10.1212/01.wnl.0000149639.25136.ca · Cited by 226
Localization and Cell Association of C1q in Alzheimer's Disease Brain
Afagh, A., Cummings, B. J., Cribbs, D. H., Cotman, C. W., & Tenner, A. J. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0043 · Cited by 224
Hsu, T. M., Konanur, V. R., Taing, L., Usui, R., Kayser, B. D., Goran, M. I., & Kanoski, S. E. (2015) · Hippocampus · doi:10.1002/hipo.22368 · Cited by 217 · cited 2×
“models, rodents show cognitive impairment and changes in behavior after HFD without presenting AD-like pathology, which may indicate a role of obesity in exacerbating rather than initiating AD (Hsu et al., 2014; Kanoski et al., 2010).”
Pro-inflammatory cytokines and their effects in the dentate gyrus
Pickering, M., & O’Connor, J. J. (2007) · Progress in Brain Research · doi:10.1016/s0079-6123(07)63020-9 · Cited by 217
Gong, J.-S., Kobayashi, M., Hayashi, H., Zou, K., Sawamura, N., Fujita, S. C., Yanagisawa, K., & Michikawa, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203934200 · Cited by 214 · cited 2×
“key function of apoE in brain is to transport cholesterol from astrocytes to neurons (Bu, 2009), and apoE4 is less efficient in doing so than apoE3 (Gong et al., 2002; Rapp et al., 2006).”
A microarray analysis of sexual dimorphism of adipose tissues in high-fat-diet-induced obese mice
Grove, K. L., Fried, S. K., Greenberg, A. S., Xiao, X. Q., & Clegg, D. J. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.12 · Cited by 208 · cited 2×
“hormones, since prepubertal ovariectomy only partially shifts the genetic profile to a more “male-like” expression (Grove et al., 2010).”
APOε4 is associated with enhanced in vivo innate immune responses in human subjects
Gale, S. C., Gao, L., Mikacenic, C., Coyle, S. M., Rafaels, N., Murray Dudenkov, T., Madenspacher, J. H., Draper, D. W., Ge, W., Aloor, J. J., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.01.032 · Cited by 202
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease
Chapuis, J., Hot, D., Hansmannel, F., Kerdraon, O., Ferreira, S., Hubans, C., Maurage, C. A., Huot, L., Bensemain, F., Laumet, G., et al. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.10 · Cited by 201 · cited 1×
“Cytokine polymorphisms have been found to interact with other AD risk factors (Di Bona et al., 2008; Lee et al., 2015), including APOE4 (Chapuis et al., 2009; Liu et al., 2014; Wang and Jia, 2010; Yu et al., 2009).”
Terwel, D., Steffensen, K. R., Verghese, P. B., Kummer, M. P., Gustafsson, J.-Å., Holtzman, D. M., & Heneka, M. T. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6546-10.2011 · Cited by 190
Corona, G., Giagulli, V. A., Maseroli, E., Vignozzi, L., Aversa, A., Zitzmann, M., Saad, F., Mannucci, E., & Maggi, M. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0480-2 · Cited by 185
Corbould, A. (2007) · Journal of Endocrinology · doi:10.1677/joe.1.07070 · Cited by 184 · cited 2×
“androgens have been reported to decrease insulin sensitivity in women’s adipose tissue (Corbould, 2007).”
Can a Bacterial Endotoxin be a Key Factor in the Kinetics of Amyloid Fibril Formation?
Asti, A., & Gioglio, L. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-131394 · Cited by 180
Lee, C. Y. D., Tse, W., Smith, J. D., & Landreth, G. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.295451 · Cited by 178 · cited 1×
“Intracellular Aβ degradation can be promoted via cholesterol efflux by accelerating trafficking of A to the endocytic system (Lee et al., 2012).”
Aβ-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease
Huang, Y. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.04.004 · Cited by 170
Tai, L. M., Bilousova, T., Jungbauer, L., Roeske, S. K., Youmans, K. L., Yu, C., Poon, W. W., Cornwell, L. B., Miller, C. A., Vinters, H. V., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.442103 · Cited by 165 · cited 1×
“Lipidation of apoE by ABCA1, which is produced by microglia and astrocytes, is also isoform-dependent with the following rank order of efficacy: apoE2 > apoE3 > apoE4 (Boehm- Cagan and Michaelson, 2014; Tai et al., 2013; Wahrle et al., 2004).”
Tai, L. M., Ghura, S., Koster, K. P., Liakaite, V., Maienschein‐Cline, M., Kanabar, P., Collins, N., Ben‐Aissa, M., Lei, A. Z., Bahroos, N., et al. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13072 · Cited by 165
Selective estrogen receptor-β activation stimulates skeletal muscle growth and regeneration
Velders, M., Schleipen, B., Fritzemeier, K. H., Zierau, O., & Diel, P. (2012) · The FASEB Journal · doi:10.1096/fj.11-194779 · Cited by 162
Direct Transcriptional Effects of Apolipoprotein E
Theendakara, V., Peters-Libeu, C. A., Spilman, P., Poksay, K. S., Bredesen, D. E., & Rao, R. V. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3562-15.2016 · Cited by 152 · cited 2×
“extent than either apoE2 or apoE3 (Theendakara et al., 2016).”
Wu, W.-F., Tan, X.-J., Dai, Y.-B., Krishnan, V., Warner, M., & Gustafsson, J.-Å. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300313110 · Cited by 149
Reversal of apoE4-driven brain pathology and behavioral deficits by bexarotene
Boehm-Cagan, A., & Michaelson, D. M. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.5198-13.2014 · Cited by 134
Rapp, A., Gmeiner, B., & Hüttinger, M. (2006) · Biochimie · doi:10.1016/j.biochi.2005.10.007 · Cited by 130 · cited 2×
“key function of apoE in brain is to transport cholesterol from astrocytes to neurons (Bu, 2009), and apoE4 is less efficient in doing so than apoE3 (Gong et al., 2002; Rapp et al., 2006).”
HSV-1 infection of human brain cells induces miRNA-146a and alzheimer-type inflammatory signaling.
Hill, J. M., Zhao, Y., Clement, C., Neumann, D. M., & Lukiw, W. J. (2009) · NeuroReport · doi:10.1097/wnr.0b013e3283329c05 · Cited by 130 · cited 1×
“…2011; Nee and Lippa, 1999; Perry et al., 2003) and some viral infections may actively contribute to AD pathogenesis, since pathogens that evade elimination by the immune system lead to chronic inflammation, neuronal damage and A deposition (Hill et al., 2009; Miklossy, 2011; Zhao and Lukiw, 2015).”
The Potential of Minocycline for Neuroprotection in Human Neurologic Disease
Zemke, D., & Majid, A. (2004) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000150867.98887.3e · Cited by 125 · cited 1×
“Furthermore, administration of minocycline, a tetracyclic antibiotic that inhibits microglial activation, ameliorates AD-like pathology in transgenic mice and downregulates inflammatory markers, partially through inhibition of NFB, and BACE-1 (Ferretti et al., 2012; Zemke and Majid, 2004).”
Farrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124
Davis, D. A., Bortolato, M., Godar, S. C., Sander, T. K., Iwata, N., Pakbin, P., Shih, J. C., Berhane, K., McConnell, R., Sioutas, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064128 · Cited by 123 · cited 1×
“Behavioral changes triggered by air pollution include memory impairment and depressive-like behaviors (Avila-Costa et al., 1999; Cheng et al., 2016a; Davis et al., 2013; Fonken et al., 2011; Morgan et al., 2011).”
Decreased glutamate + glutamine in Alzheimer’s disease detected in vivo with 1 H-MRS at 0.5 T
Antuono, P. G., Jones, J. L., Wang, Y., & Li, S.-J. (2001) · Neurology · doi:10.1212/wnl.56.6.737 · Cited by 119
Hippocampal expression of murine TNFα results in attenuation of amyloid deposition in vivo
Chakrabarty, P., Herring, A., Ceballos-Diaz, C., Das, P., & Golde, T. E. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-16 · Cited by 117
Avila-Muñoz, E., & Arias, C. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.07.004 · Cited by 114 · cited 1×
“Interestingly, levels of pro-inflammatory cytokines are elevated in serum even before there is detectable Aβ pathology (Avila-Muñoz and Arias, 2014; Eikelenboom et al., 2011), pointing to a role for inflammation in the initiation of disease.”
Puy, L., MacLusky, N. J., Becker, L., Karsan, N., Trachtenberg, J., & Brown, T. J. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00165-v · Cited by 113
Mid‐life adiposity factors relate to blood–brain barrier integrity in late life
Gustafson, D. R., Karlsson, C., Skoog, I., Rosengren, L., Lissner, L., & Blennow, K. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01869.x · Cited by 107 · cited 1×
“During this period, adiposity is correlated with obesity-related vascular diseases, increased inflammation, and changes in blood-brain barrier integrity and brain morphology (Emmerzaal et al., 2015; Gustafson et al., 2007; Pannacciulli et al., 2006; Yaffe et al., 2004).”
Apolipoprotein E Receptors Mediate the Effects of β-Amyloid on Astrocyte Cultures
LaDu, M. J., Shah, J. A., Reardon, C. A., Getz, G. S., Bu, G., Hu, J., Guo, L., & Van Eldik, L. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000602200 · Cited by 103 · cited 2×
“ApoE4 has been shown to increase susceptibility to inflammation (LaDu et al., 2000), in both animal models and in humans.”
The Gastrointestinal Tract Microbiome and Potential Link to Alzheimer’s Disease
Hill, J. M., Bhattacharjee, S., Pogue, A. I., & Lukiw, W. J. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00043 · Cited by 98 · cited 1×
“Further, recent reviews have suggested a link between AD and the microbiome (Bhattacharjee and Lukiw, 2013; Hill et al., 2014a; 2014b; Shoemark and Allen, 2015), an idea supported by evidence of relationships between the microbiome, systemic inflammation, brain inflammation, and cognitive…”
Walker, D. G., Whetzel, A. M., Serrano, G., Sue, L. I., Beach, T. G., & Lue, L.-F. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.09.023 · Cited by 93 · cited 1×
“Interestingly, two interactive regulators of microglial phagocytosis, CD33 and TREM2, have polymorphisms linked to increased risk for AD (Ma et al., 2014; Walker et al., 2015).”
Gender differences in predictors of mortality in nursing home residents with AD
Lapane, K. L., Gambassi, G., Landi, F., Sgadari, A., Mor, V., & Bernabei, R. (2001) · Neurology · doi:10.1212/wnl.56.5.650 · Cited by 91
Fonseca, M. I., Chu, S., Pierce, A. L., Brubaker, W. D., Hauhart, R. E., Mastroeni, D., Clarke, E. V., Rogers, J., Atkinson, J. P., & Tenner, A. J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149792 · Cited by 87
Apolipoprotein E isoform mediated regulation of nitric oxide release
Brown, C. M., Wright, E., Colton, C. A., Sullivan, P. M., Laskowitz, D. T., & Vitek, M. P. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00803-1 · Cited by 84 · cited 3×
“nitric oxide (NO) than those from APOE3-TR male mice, but female macrophages show no difference between APOE3 and APOE4 (Brown et al., 2002).”
InfluentialElevated CNS Inflammation in Patients with Preclinical Alzheimer's Disease
Monson, N. L., Ireland, S. J., Ligocki, A. J., Chen, D., Rounds, W. H., Li, M., Huebinger, R. M., Munro Cullum, C., Greenberg, B. M., Stowe, A. M., et al. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.183 · Cited by 76 · cited 1×
“Human astrocytes synthesize Aβ- 40 and -42 when stimulated by IF, TNF or IL-1, events that can occur early in AD development (Blasko et al., 2000; Monson et al., 2014).”
Sex steroids, APOE genotype and the innate immune system
Colton, C. A., Brown, C. M., & Vitek, M. P. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.08.001 · Cited by 71 · cited 3×
“testosterone via castration results in a significant increase in levels of nitrite and cytokines in APOE3-TR but not APOE4-TR males (Colton et al., 2005).”
InfluentialHara, M., Matsushima, T., Satoh, H., Iso-o, N., Noto, H., Togo, M., Kimura, S., Hashimoto, Y., & Tsukamoto, K. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000054199.78458.4b · Cited by 53 · cited 1×
“Cholesterol efflux activity is apoE isoform- dependent and APOE4 carriers have poorer efficiency of cholesterol efflux, which possibly contributes to the higher risk of AD in APOE4 carriers (Hara, 2002; Jiang et al., 2008a; 2008b; Michikawa et al., 2000).”
Chace, C., Pang, D., Weng, C., Temkin, A., Lax, S., Silverman, W., Zigman, W., Ferin, M., Lee, J. H., Tycko, B., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110860 · Cited by 53
APOE epsilon-4 allele and cytokine production in Alzheimer's disease
Olgiati, P., Politis, A., Malitas, P., Albani, D., Dusi, S., Polito, L., De Mauro, S., Zisaki, A., Piperi, C., Stamouli, E., et al. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2344 · Cited by 35 · cited 1×
“As in animal models, apoE4 is associated with greater baseline as well as LPS- stimulated levels of inflammatory cytokines among non-AD (Gale et al., 2014) and AD patients (Olgiati et al., 2010).”
Cited by
Ageing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310
Zheng, G., Qiu, P., Xia, R., Lin, H., Ye, B., Tao, J., & Chen, L. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00098 · Cited by 242
The impact of obesity on neurodegenerative diseases.
Mazon, J. N., de Mello, A. H., Ferreira, G. K., & Rezin, G. T. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.06.002 · Cited by 185
Clinical effects of air pollution on the central nervous system; a review
Babadjouni, R. M., Hodis, D. M., Radwanski, R., Durazo, R., Patel, A., Liu, Q., & Mack, W. J. (2017) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2017.04.028 · Cited by 177
Gene-environment interactions in Alzheimer's disease: A potential path to precision medicine
Eid, A., Mhatre, I., & Richardson, J. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.03.005 · Cited by 164
Metadata
- Authors
- Uchoa, M. F., Moser, V. A., & Pike, C. J.
- Venue
- Frontiers in Neuroendocrinology
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 43
- Pages
- 60-82
- ISSN
- 0091-3022 (ISSN-L)
- OpenAlex
- W2520428971
- Cited by
- 102
- References
- 174
- FWCI
- 7.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.